FITC Mouse Anti-Human DAF/CD55 Antibody (S-628-1)

產(chǎn)品型號：S0B5395

更新時間：2025-10-09

廠商性質(zhì)：生產(chǎn)廠家

訪問量：46

服務(wù)熱線

15855403091

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對抗體病理/IHC抗體

查看全部產(chǎn)品

相關(guān)文章

乳腺病理免疫組化解碼：從標記物判讀到陷阱規(guī)避全指南

成纖維細胞生長因子-1（FGF1）如何重編程疾病命運與國自然研究新范式

大鼠免疫球蛋白的免疫功能及應(yīng)用價值

視黃醇結(jié)合蛋白4（RBP4）抗體：發(fā)掘其在疾病風險中的診斷潛力

產(chǎn)品介紹

Decay-accelerating factor （DAF, also known as CD55） is a complement regulatory protein that plays a crucial role in protecting cells from complement-mediated attack. It is a membrane lipid microdomain-associated, GPI-anchored protein that accelerates the decay of C3 and C5 convertases, which are essential for the downstream formation of the membrane attack complex （MAC） in the complement cascade. This action helps prevent excessive complement activation and subsequent cell damage. CD55 is involved in various physiological and pathological processes, including immune regulation, cancer progression, and tissue protection. In cancer, CD55 can promote malignant transformation, cell survival, angiogenesis, and inhibit apoptosis through intracellular signaling pathways such as JNK, JAK/STAT, MAPK/NF-κB, and LCK. Additionally, it is enriched in the cancer stem cell niche and can be induced by chemotherapeutics and hypoxic environments.

上一個：S0B5391FITC Mouse Anti-Human NCAM-1/CD56 Antibody (S-577-58)